Both of these GLP-1 drugs were originally designed for diabetes, but their benefits keep expanding — KSTP health expert Dr.

Zepbound is the newest GLP-1 medication to be approved by the Food and Drug Administration (FDA) for weight loss. It’s available only by prescription for people with a body mass index (BMI) of ...

It matters who gets them." The fine print on the latest ad reads, “Zepbound is not for cosmetic weight loss.” Glaser was right. Ozempic was the frontrunner of online conversations during and ...

Opinions expressed by Forbes Contributors are their own. Dr. Omer Awan is a practicing physician who covers public health. CARLSBAD, CA-NOV 30TH: Mounjaro injection pen on display at Rachel Graham ...

Joshua Cohen is a Boston-based writer who covers health policy. Patients on the weight-loss drug Zepbound regained weight almost one year after stopping treatment, according to a study published ...

Following positive results from its SURMOUNT-5 trial, Eli Lilly’s Zepbound (tirzepatide) will surpass Novo Nordisk’s Weogvy (semaglutide) in the obesity treatment market, according to a ...

Not long after reporting phase 2 data for one of its obesity candidates that appeared to put it on par with Eli Lilly’s Zepbound, Kailera Therapeutics is preparing for an eventual market launch ...